Profile data is unavailable for this security.
About the company
Hims & Hers Health, Inc., formerly Oaktree Acquisition Corp., is a telehealth platform that connects consumers to licensed healthcare professionals. The Company has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. The Company has partnered with dermatology experts to offer access to formulated topical creams for customers experiencing acne and signs of premature aging, such as wrinkles. It offers telehealth solutions with combined access to a distributed provider network, digital prescriptions, cloud pharmacy, and consumer engagement strategies, all delivered through mobile and Web interfaces. The Company's Products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer.
- Revenue in USD (TTM)373.75m
- Net income in USD-83.03m
- Incorporated2021
- Employees398.00
- LocationHims & Hers Health Inc2269 Chestnut St, #523SAN FRANCISCO 94123United StatesUSA
- Phone+1 (415) 851-0195
- Fax+1 (302) 655-5049
- Websitehttps://www.forhims.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Travere Therapeutics Inc | 213.40m | -264.23m | 1.28bn | 310.00 | -- | 12.75 | -- | 6.02 | -4.18 | -4.18 | 3.38 | 1.57 | 0.2843 | 1.12 | 16.39 | 688,383.90 | -35.20 | -21.88 | -42.04 | -25.92 | 96.36 | 97.04 | -123.82 | -73.53 | 4.03 | -24.57 | 0.7884 | -- | 14.71 | 11.23 | 4.61 | -- | 15.16 | -- |
| Verve Therapeutics Inc | 929.00k | -147.64m | 1.32bn | 113.00 | -- | 2.36 | -- | 1,420.40 | -2.90 | -2.90 | 0.0183 | 9.07 | 0.0017 | -- | -- | 8,221.24 | -27.23 | -- | -28.53 | -- | -- | -- | -15,892.25 | -- | -- | -- | 0.00 | -- | -- | -- | -163.25 | -- | -- | -- |
| Medifast Inc | 1.64bn | 151.07m | 1.33bn | 984.00 | 9.20 | 8.80 | 8.35 | 0.8083 | 13.18 | 13.18 | 143.01 | 13.77 | 4.70 | 3.30 | -- | 1,665,818.00 | 43.30 | 40.99 | 78.98 | 64.91 | 72.30 | 74.68 | 9.22 | 10.78 | 0.5465 | 324.70 | 0.00 | 47.61 | 63.25 | 40.93 | 59.47 | 55.86 | 64.09 | 39.63 |
| Allogene Therapeutics Inc | 247.00k | -312.65m | 1.35bn | 356.00 | -- | 1.83 | -- | 5,476.48 | -2.20 | -2.20 | 0.0017 | 5.14 | 0.0003 | -- | -- | 796.77 | -31.79 | -- | -33.54 | -- | -- | -- | -126,580.20 | -- | -- | -- | 0.00 | -- | -- | -- | -2.71 | -- | -- | -- |
| BridgeBio Pharma Inc | 88.66m | -490.77m | 1.37bn | 576.00 | -- | -- | -- | 15.46 | -3.35 | -3.35 | 0.6054 | -7.62 | 0.1174 | -- | -- | 153,930.60 | -65.73 | -- | -77.58 | -- | 95.11 | -- | -559.83 | -- | -- | -- | 2.99 | -- | 745.14 | -- | -25.36 | -- | -- | -- |
| Keros Therapeutics Inc | 20.00m | -81.90m | 1.38bn | 104.00 | -- | 5.41 | -- | 68.86 | -3.36 | -3.36 | 0.8245 | 9.24 | 0.0829 | -- | 126.98 | 333,333.30 | -33.95 | -- | -35.61 | -- | -- | -- | -409.51 | -- | -- | -43,848.00 | 0.00 | -- | -- | -- | -29.01 | -- | -- | -- |
| Novavax Inc | 1.85bn | -1.32bn | 1.38bn | 1.54k | -- | -- | -- | 0.7486 | -17.25 | -17.25 | 23.84 | -7.21 | 0.7641 | -- | 16.67 | 1,198,360.00 | -54.70 | -70.99 | -187.25 | -148.09 | 48.93 | -- | -71.59 | -156.11 | 1.01 | -60.34 | -- | -- | 141.02 | 136.93 | -316.91 | -- | 25.86 | -- |
| Hims & Hers Health Inc | 373.75m | -83.03m | 1.39bn | 398.00 | -- | 4.35 | -- | 3.73 | -0.411 | -0.411 | 1.85 | 1.54 | 1.03 | 7.22 | 120.92 | 939,067.80 | -22.82 | -- | -25.76 | -- | 74.62 | -- | -22.22 | -- | 3.79 | -421.02 | 0.00 | -- | -- | -- | -3,430.95 | -- | -- | -- |
| Cassava Sciences Inc | 0.00 | -71.28m | 1.41bn | 24.00 | -- | 6.80 | -- | -- | -1.78 | -1.78 | 0.00 | 4.96 | 0.00 | -- | -- | 0.00 | -29.61 | -21.19 | -30.53 | -22.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -411.29 | -- | 212.11 | -- |
| Amphastar Pharmaceuticals Inc | 484.85m | 77.23m | 1.42bn | 1.76k | 19.73 | 2.83 | 13.77 | 2.93 | 1.49 | 1.49 | 9.32 | 10.39 | 0.7035 | 2.47 | 6.25 | 275,327.10 | 11.40 | 3.96 | 13.34 | 5.03 | 48.25 | 40.89 | 16.20 | 6.57 | 2.75 | 159.72 | 0.1303 | 0.00 | 25.13 | 11.40 | 4,327.37 | 44.62 | 5.13 | -- |
| Reata Pharmaceuticals Inc | 3.15m | -311.78m | 1.45bn | 346.00 | -- | 321.26 | -- | 461.04 | -8.55 | -8.55 | 0.0864 | 0.1233 | 0.0048 | -- | -- | 9,101.16 | -47.40 | -40.52 | -54.53 | -50.27 | -- | -- | -9,901.05 | -663.02 | -- | -- | 0.00 | -- | 27.40 | -25.44 | -10.16 | -- | 31.34 | -- |
| Chinook Therapeutics Inc | 56.85m | -117.77m | 1.46bn | 138.00 | -- | 3.06 | -- | 25.61 | -1.83 | -1.83 | 0.9482 | 7.44 | 0.1168 | -- | 38.81 | 411,971.00 | -24.19 | -22.27 | -26.02 | -24.07 | -- | -- | -207.14 | -441.76 | -- | -27.86 | 0.00 | -- | 6,142.44 | 0.3698 | -26.11 | -- | -39.87 | -- |
| Rocket Pharmaceuticals Inc | 0.00 | -199.39m | 1.50bn | 151.00 | -- | 3.51 | -- | -- | -3.06 | -3.06 | 0.00 | 5.41 | 0.00 | -- | -- | 0.00 | -42.09 | -31.02 | -44.66 | -32.83 | -- | -- | -- | -- | -- | -- | 0.054 | -- | -- | -- | -21.02 | -- | 87.27 | -- |
| SpringWorks Therapeutics Inc | 0.00 | -259.31m | 1.51bn | 222.00 | -- | 2.47 | -- | -- | -5.19 | -5.19 | 0.00 | 9.82 | 0.00 | -- | -- | 0.00 | -44.07 | -- | -47.18 | -- | -- | -- | -- | -- | -- | -272.17 | 0.0093 | -- | -100.00 | -- | -281.60 | -- | -- | -- |
Data as of Dec 06 2022. Currency figures normalised to Hims & Hers Health Inc's reporting currency: US Dollar USD
17.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2022 | 10.83m | 5.45% |
| BlackRock Fund Advisorsas of 30 Sep 2022 | 7.44m | 3.75% |
| Oaktree Capital Management LPas of 30 Sep 2022 | 3.27m | 1.65% |
| SSgA Funds Management, Inc.as of 30 Sep 2022 | 3.02m | 1.52% |
| Marshall Wace LLPas of 30 Sep 2022 | 2.25m | 1.13% |
| Geode Capital Management LLCas of 30 Sep 2022 | 2.12m | 1.07% |
| Franklin Advisers, Inc.as of 30 Sep 2022 | 1.79m | 0.90% |
| Canada Pension Plan Investment Boardas of 30 Sep 2022 | 1.58m | 0.79% |
| Renaissance Technologies LLCas of 30 Sep 2022 | 1.51m | 0.76% |
| American Century Investment Management, Inc.as of 30 Sep 2022 | 1.49m | 0.75% |
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
